
- Posted in Voice of Industry | July 19, 2012 | Comments (0)
- Tags: fda, supply chain, regulatory, omtec, federal regulations, opening panel discussion, government regulation, supply chain management, orthopedic industry, regulatory affairs, regulatory compliance
- By: BONEZONE
The State and Future of the Orthopaedic Industry:
A High Altitude View
(Part 5 of 6)
— "Is the FDA in the 'denial' business?" "Is the FDA just in an 'anti-industry' phase, or will this trend become the new status quo?" "What is the impact of regulatory compliance policy on the supply chain?" |
In response to unresolved challenges facing the orthopaedic industry (e.g. global economic turmoil, slowing markets, inflation, market consolidation, etc.), the 2012 OMTEC Opening Panel Discussion sought to extract actionable advice and insight from respected industry leaders on how to translate today’s issues into relatable language, and then prepare to act. Panel members represented select sectors from the orthopaedic supply chain, including: Moderator: Panelists: |
— To view the remaining parts from the OMTEC 2012 - Opening Panel Discussion, please follow the below links: Part 1: Market Growth Rates in Orthopaedics Part 2: Medical Device Excise Tax Part 3: Trends in Innovation and R&D Investment |